24 Jul, EOD - Indian

SENSEX 80148.88 (-0.35)

Nifty 50 24413.5 (-0.27)

Nifty Bank 51317 (-0.89)

Nifty IT 40115.05 (0.18)

Nifty Midcap 100 56872.75 (1.04)

Nifty Next 50 71844.65 (0.30)

Nifty Pharma 20908.5 (0.74)

Nifty Smallcap 100 18723.5 (1.76)

24 Jul, EOD - Global

NIKKEI 225 39154.85 (-1.11)

HANG SENG 17311.05 (-0.91)

DOW JONES 40043.34 (-0.78)

S&P 5461.87 (-1.69)

Login/Signup

Bajaj Consumer Care Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 533229 | NSE Symbol : BAJAJCON | ISIN : INE933K01021 | Industry : FMCG |


Board Meeting
Announcement Date Date Of Meeting Purpose
29-Apr-2024 08-May-2024 Audited Results & Buy Back of Shares Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2024 ,inter alia, to consider and approve Meeting of Board of Directors of the Company is scheduled on Wednesday, May 8, 2024, inter alia, to consider and approve: 1) Audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the quarter and financial year ended March 31, 2024. 2) Audited Consolidated Financial Results of the Company and its subsidiaries under Ind AS for the quarter and financial year ended March 31, 2024. 3) Auditors' Report on Standalone and Consolidated Annual Financial Statements, Directors' Report (including Management Discussion and Analysis Report), Report on Corporate Governance, Business Responsibility and Sustainability Report for the financial year ended March 31, 2024 and notice convening 18th Annual General Meeting of the Company. 4) Proposal for buyback of fully paid-up equity shares of the Company, in accordance with the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018, including matters related / incidental thereto. Outcome of the Board Meeting held on May 8, 2024 In furtherance of our intimation letter dated April 29, 2024 and in terms of Regulation 30 of the SEBI LODR Regulations, the board of directors of Bajaj Consumer Care Limited (the 'Company') at its meeting held today, has considered and approved the proposal for buyback of fully paid up equity shares of the Company having a face value of ? 1/- (Indian Rupee One Only) ('Equity Shares' and such buyback 'Buyback') not exceeding 57,41,000 Equity Shares (representing 4.02% of the total number of Equity Shares in the total paid-up equity capital of the Company as of March 31, 2024) from all shareholders/ beneficial owners of the Equity Shares of the Company, as on record date, which will be decided subsequently, through the 'tender offer' route, on a proportionate basis, using mechanism for acquisition of shares through stock exchange as prescribed under Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended (the 'SEBI Buyback Regulations') and such other circulars or notifications issued by the Securities and Exchange Board of India and the Companies Act, 2013 and rules made thereunder, as amended from time to time, subject to the approval of the shareholders of the Company, by way of a special resolution through postal ballot (including e-voting) pursuant to section 110 of the Companies Act, 2013 read with the rules framed thereunder and all other applicable statutory approvals at a price of ? 290/- (Indian Rupees Two Hundred and Ninety only) per Equity Share ('Buyback Price'), payable in cash, for an aggregate amount not exceeding ? 16,649 lacs (Indian Rupees Sixteen Thousand Six Hundred and Forty nine lacs only), excluding any expenses incurred, or to be incurred for the Buyback viz., brokerage costs, fees, turnover charges, taxes such as buyback tax, securities transaction tax and goods and services tax (if any), stamp duty, advisors fees, printing and dispatch, if any, filing fees to SEBI and any appropriate authorities, stock exchange charges, advisor/legal fees, public announcement publication expenses and other incidental and related expenses and charges ('Transaction Costs'), (such maximum amount hereinafter referred to as the 'Buyback Offer Size'). The Buyback Offer Size represents 19.25% and 20.00% of the aggregate of the Company's fully paid-up equity capital and free reserves based on both latest standalone and consolidated audited financial statements of the Company, respectively, for the financial year ended on March 31, 2024, which is less than 25% of the aggregate of the total paid-up capital and free reserves of the Company in accordance with Regulation 4(i) read with provision to Regulation 5(i)(b) of the SEBI Buyback Regulations. The Buyback is subject to approval of the shareholders by means of a special resolution through postal ballot. The public announcement and letter of offer setting out the process, timelines and other requisite details will be released in due course in accordance with the SEBI Buyback Regulations. The Board has constituted the Buyback Committee' and delegated its powers to do such acts, deeds, matters, and things as it may, in its absolute discretion, deem necessary, expedient, usual or proper in relation to the proposed Buyback, and has appointed Mr. Vivek Mishra, Head-Legal & Company Secretary as the compliance officer for the purposes of the proposed Buyback. The Board has appointed IIFL Securities Limited as the merchant banker to the Buyback or manager to the Buyback in accordance with the Companies Act, as amended and SEBI Buyback Regulations, be and hereby ratified and approved. The details of the pre-Buyback shareholding pattern of the Company is enclosed as Annexure A. The postBuyback shareholding pattern of the Company shall be ascertained subsequently. We had vide our letter dated March 30, 2024, we had intimated that the 'Trading Window' for dealing in securities of the Company, shall remain closed for all the 'Designated Persons' covered under Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (Code of Conduct), from April 1, 2024 till 48 hours after the announcement of Audited Financial Results of the Company for the year ending March 31, 2024. Further, we would like to inform you that the 'Trading Window' for dealing in securities of the Company shall remain closed for all the 'Designated Persons' until completion of buyback. The above information is also available on the website of the Company, i.e. www.bajajconsumercare.com. The same may please be taken on record and suitably disseminated to all concerned. (As The details of the pre-Buyback shareholding pattern of the Company is enclosed as Annexure A. The postBuyback shareholding pattern of the Company shall be ascertained subsequently. We had vide our letter dated March 30, 2024, we had intimated that the 'Trading Window' for dealing in securities of the Company, shall remain closed for all the 'Designated Persons' covered under Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (Code of Conduct), from April 1, 2024 till 48 hours after the announcement of Audited Financial Results of the Company for the year ending March 31, 2024. Further, we would like to inform you that the 'Trading Window' for dealing in securities of the Company shall remain closed for all the 'Designated Persons' until completion of buyback. The above information is also available on the website of the Company, i.e. ww.bajajconsumercare.com. The same may please be taken on record and suitably disseminated to all concerned. Outcome of the Board Meeting held on May 8, 2024 (As Per BSE Announcement Dated on 08.05.2024)
29-Jan-2024 05-Feb-2024 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 inter alia to consider and approve Meeting of Board of Directors of the Company is scheduled on Monday February 5 2024 inter alia to approve the Unaudited Financial Results (Standalone and Consolidated) for the third quarter ended December 31 2023. Further the Board will also consider declaration of interim dividend for the FY 2023-24 at the aforesaid Board Meeting. Recommended an Interim Dividend at the rate of 300% i.e. Rs. 3/- per share of Re. 1/- each and that the same shall be paid to the Equity Shareholders of the Company whose names appear on the Register of Members of the Company or in the records of the Depositories as beneficial owners of the shares as on Saturday, February 17, 2024, which is the Record Date fixed for the purpose. (As Per BSE Bulletin Dated on 05.02.2024) Outcome of Board Meeting. Change in Directorate The Board has approved Interim dividend @ 300% i.e. Rs. 3/- per share. (As per BSE Announcement Dated on 05/02/2024)
01-Nov-2023 09-Nov-2023 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of Board of Directors of the Company is scheduled on Thursday November 9 2023 inter alia to approve the Unaudited Financial Results (Standalone and Consolidated) for the second quarter/half year ended September 30 2023. With regard to the captioned matter and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the meeting of the Board of Directors of the Company commenced at 9:45 A.M. and concluded at 11:00 A.M. today i.e. November 9, 2023, the Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2023, of the financial year 2023-24 (copy attached herewith). The aforesaid results were reviewed by the Audit Committee and subsequently approved and taken on record by the Board of Directors of the Company. We would further like to inform you that the Statutory Auditors of the Company have subjected the aforesaid results to 'Limited Review' and the same is enclosed herewith. The same may please be taken on record and suitably disseminated to all concerned. Outcome of Board Meeting held on November 9, 2023. (As per BSE Announcement Dated on 09/11/2023)
31-Jul-2023 09-Aug-2023 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of Board of Directors of the Company is scheduled on Wednesday August 9 2023 inter alia to approve the Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30 2023. The Board of Directors have Inter alia approved Unaudited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2023, of the financial year 2023-24 (copy attached herewith). (As Per BSE Announcement Dated on 09.08.2023)
24-Apr-2023 03-May-2023 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2023 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI LODR that the meeting of Board of Directors of the Company is scheduled on Wednesday May 3 2023 inter alia to consider and approve the following: 1) Audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the quarter and financial year ended March 31 2023. 2) Audited Consolidated Financial Results of the Company and its subsidiaries under Ind AS for the quarter and financial year ended March 31 2023. 3) Auditors Report on Standalone and Consolidated Annual Financial Statements Directors Report (including Management Discussion and Analysis Report) Report on Corporate Governance Business Responsibility and Sustainability Report for the financial year ended March 31 2023 and notice convening 17th Annual General Meeting of the Company. 4) Recommend a final dividend (if any) for the approval of shareholders at the ensuing Annual General Meeting. quarter and financial year ended March 31, 2023, Audited Annual Financial Statements (Standalone and Consolidated) for the financial year ended March 31, 2023, together with Auditors'' Report with unmodified opinion thereon. A declaration pursuant to Regulation 33(3)(d) of Listing Regulations (as amended) and in compliance with SEBI Circular CIR/CFD/CMD/56/2016 dated May 27, 2016 is enclosed herewith. (The Audited Financial Results approved by the Board of Directors together with Statutory Auditors Report thereon are also attached herewith for your ready reference). 2. Recommended Final Dividend of 500% (i.e. Rs. 5/- per share, on equity shares of the face value of Re. 1 /- each) for the financial year ended March 31, 2023. Information regarding book closure and date of payment of final dividend, if approved by the shareholders at the forthcoming Annual General Meeting of the Company will be made separately. The Board at its meeting held on May 3, 2023 recommended Final Dividend of 500% (i.e. Rs. 5/- per share, on equity shares of the face value of Re. 1 /- each) for the financial year ended March 31, 2023. Information regarding book closure and date of payment of final dividend, if approved by the shareholders at the forthcoming Annual General Meeting of the Company will be made separately. (As Per BSE Announcement Dated on 03.05.2023)
01-Feb-2023 09-Feb-2023 Quarterly Results Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of Board of Directors of the Company is scheduled on Thursday, February 9, 2023, inter alia, to approve the Unaudited (Provisional) Financial Results (Standalone and Consolidated) for the third quarter ended December 31, 2022. With regard to the captioned matter and in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the meeting of the Board of Directors of the Company which commenced at 3:00 P.M. and concluded at 4:00 P.M. today i.e. February 9, 2023, the Board of Directors have Inter alia approved Unaudited (Provisional) Financial Results (Standalone and Consolidated) for the third quarter ended December 31, 2022, of the financial year 2022-23 (copy attached herewith). Outcome of Board Meeting held on February 9, 2023 (As Per BSE Announcement Dated on 09/02/2023) Pursuant to the Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith copies each of Economic Times (English Daily) and Jai Rajasthan (Hindi Daily) both dated November 11, 2023, for publication of extracts of Consolidated Unaudited Audited Financial Results for the third quarter ended December 31 2022 (As Per BSE Announcement Dated on 13/02/2023)
05-Dec-2022 09-Dec-2022 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/12/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and other applicable regulations of the SEBI Listing Regulations the Board of Directors of the Company will consider a proposal for buyback of fully paid-up equity shares of the Company at its meeting to be held on Friday December 9 2022 in accordance with the Securities and Exchange Board of India (Buy-back of Securities) Regulations 2018. With regard to the captioned matter, this is to inform you that pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended and Company''s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders (Code of Conduct), the 'Trading Window' for dealing in securities of the Company shall remain closed for all the 'Designated Persons' covered under the Code of Conduct from December 5, 2022 till December 12, 2022 after the announcement of outcome of Board Meeting scheduled on December 9, 2022. In furtherance of our intimation letter dated December 5, 2022, please find attached outcome of board meeting held on December 9, 2022. (As per BSE Announcement Dated on 09/12/2022)
01-Nov-2022 09-Nov-2022 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of Board of Directors of the Company is scheduled on Wednesday November 9 2022 inter alia to approve the Unaudited (Provisional) Financial Results (Standalone and Consolidated) for the second quarter/half year ended September 30 2022. Further vide our letter dated September 30 2022 we had intimated that the Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons covered under Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders (Code of Conduct) from October 1 2022 till 48 hours after the announcement of Un-audited Financial Results of the Company for the second quarter/half year ending September 30 2022. The notice is also available on the website of the Company at www.bajajconsumercare.com. Outcome of Board Meeting held on November 9, 2022 (As Per BSE Announcement Dated on 09/11/2022)
25-Jul-2022 01-Aug-2022 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2022 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of Board of Directors of the Company is scheduled on Monday August 1 2022 inter alia to approve the Unaudited (Provisional) Financial Results (Standalone and Consolidated) for the first quarter ended June 30 2022. Further vide our letter dated June 30 2022 we had intimated that the Trading Window for dealing in securities of the Company shall remain closed for all the Designated Persons covered under Companys Code of Conduct for Regulating Monitoring and Reporting of Trading by Insiders (Code of Conduct) from July 1 2022 till 48 hours after the announcement of Un-audited Financial Results of the Company for the quarter ending June 30 2022. The notice is also available on the website of the Company at www.bajajconsumercare.com Outcome of Board Meeting held on August 1, 2022 (As Per BSE Announcement Dated on 01.08.2022)
28-Apr-2022 06-May-2022 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/05/2022 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of Board of Directors of the Company is scheduled on Friday May 6 2022 in Mumbai to inter alia consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended March 31 2022 together with Auditors Report on Standalone and Consolidated Annual Financial Statements Directors Report (including Management Discussion and Analysis Report) Report on Corporate Governance Business Responsibility Report Notice convening 16th Annual General Meeting of the Company and recommendation of final dividend (if any) for the financial year ended March 31 2022. Bajaj Consumer Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2022, inter alia, has recommended Final Dividend of 400% (i.e. Rs. 4/- per share, on Equity Shares of the Face Value of Re. 1 /- each) for the Financial Year ended March 31, 2022. Outcome of Board Meeting held on May 6, 2022. (As Per BSE Announcement Dated on 06.05.2022)
25-Jan-2022 02-Feb-2022 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of Board of Directors of the Company is scheduled on Wednesday February 2 2022 through Audio-Visual means as per the notification issued by Ministry of Corporate Affairs dated March 19 2020 inter alia to approve the Unaudited Financial Results (Standalone and Consolidated) for the third quarter ended December 31 2021. We would further like to inform you that the Board may also consider proposal for declaration of interim dividend on equity shares of the Company at the aforesaid Board Meeting. Bajaj Consumer Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 02, 2022, inter alia, has recommended an Interim Dividend at the rate of 400% i.e. Rs. 4/- per share of Re. 1 /- each. Further, the aforesaid interim dividend shall be paid to the eligible shareholders from February 28, 2022 onwards. Outcome of Board Meeting held on February 2, 2022 (As Per BSE Announcement Dated on 02.02.2022)
25-Oct-2021 01-Nov-2021 Quarterly Results Outcome of Board Meeting held on November 1, 2021 (As per BSE Announcement Dated on 01/11/2021)
28-Jul-2021 05-Aug-2021 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2021 ,inter alia, to consider and approve Un-audited Financial Results (Standalone and Consolidated) for the first quarter ended June 30, 2021 of the financial year 2021-22. The same may please be taken on record and suitably disseminated to all concerned. Please find attached unaudited financial results for the quarter ended June 30, 2021 (As Per BSE Announcement dated on 05.08.2021)
12-Apr-2021 19-Apr-2021 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/04/2021 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of Board of Directors of the Company is scheduled on Monday, April 19, 2021 through Audio-Visual means as per the notification issued by Ministry of Corporate Affairs dated 19th March, 2020, inter alia, to approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended March 31, 2021 together with Auditors' Report on Standalone and Consolidated Annual Financial Statements, Directors' Report (including Management Discussion and Analysis Report), Report on Corporate Governance, Business Responsibility Report, Notice convening 15th Annual General Meeting of the Company and recommendation of final dividend (if any), for the financial year ended March 31, 2021. Please find attached outcome of Board Meeting Bajaj Consumer Care Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 19, 2021, inter alia, has recommended Final Dividend of 400% (i.e. Rs. 4/- per share, on Equity Shares of the Face Value of Re. 1/- each) for the Financial Year ended March 31, 2021. (As Per BSE Announcement dated on 19.04.2021)
25-Jan-2021 03-Feb-2021 Bajaj Consumer Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2021 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that the meeting of Board of Directors of the Company is scheduled on Wednesday, February 3, 2021 through Audio-Visual means as per the notification issued by Ministry of Corporate Affairs dated March 19, 2020, inter alia, to approve the Un-audited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2020. We would further like to inform you that the Board may also consider proposal for declaration of interim dividend on equity shares of the Company at the aforesaid Board Meeting. Interim Dividend of 600% i.e. Rs. 6/- per equity share for the year 2020-21 (As Per BSE Announcement dated on 03.02.2021)
1 2 3  Next